The potential risk of AVM rupture was evaluated during the A Randomized trial of Unruptured Brain Arteriovenous malformations (ARUBA) trial. This review unveiled a lessened threat of stroke and mortality in people managed conservatively compared to clients who underwent interventional therapy.[thirteen]  The ARUBA trial in contrast health-related management alone to https://www.sgvascularctr.com/service/vascular-malformations/